Papers: 10.1080/19420862.2020.1862452
https://doi.org/10.1080/19420862.2020.1862452
Preclinical optimization of Ly6E-targeted ADCs for increased durability and efficacy of anti-tumor response
Cited by: 9
Author(s): Josefa Chuh, MaryAnn Go, Yvonne Chen, Jun Guo, Hanine Rafidi, Danielle Mandikian, Yonglian Sun, Zhonghua Lin, Kellen Schneider, Pamela Zhang, Rajesh Vij, Danielle Sharpnack, Pamela Chan, Cecile de la Cruz, Jack Sadowsky, Dhaya Seshasayee, James T. Koerber, Thomas H. Pillow, Gail D. Lewis Phillips, Rebecca K. Rowntree, C. Andrew Boswell, Katherine R. Kozak, Andrew G. Polson, Paul Polakis, Shang‐Fan Yu, Peter S. Dragovich, Nicholas J. Agard
Published: almost 6 years ago
Software Mentions 1
Very Likely Science (100)